Patents by Inventor Paul BEVAN

Paul BEVAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10620208
    Abstract: The present invention relates to a carbonic anhydrase IX targeting compound for the use in the treatment of cancer, wherein the use comprises quantifying CAIX expression as well as the determination of a CAIX score based on the CAIX expression. The present invention relates further to a method for diagnosing, predicting and/or classifying a cancer disease comprising quantifying CAIX expression, and the determination of a CAIX score.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: April 14, 2020
    Assignee: Wilex AG
    Inventors: Olaf Wilhelm, Paul Bevan, Barbara Fall, Pia Klöpfer
  • Publication number: 20160002350
    Abstract: The present invention relates to a carbonic anhydrase IX targeting compound for the use in the treatment of cancer, wherein the use comprises quantifying CAIX expression as well as the determination of a CAIX score based on the CAIX expression. The present invention relates further to a method for diagnosing, predicting and/or classifying a cancer disease comprising quantifying CAIX expression, and the determination of a CAIX score.
    Type: Application
    Filed: February 21, 2014
    Publication date: January 7, 2016
    Applicant: WILEX AG
    Inventors: Olaf WILHELM, Paul BEVAN, Barbara FALL, Pia KLÖPFER